RVL Pharmaceuticals plc Annual Return On Equity in % from 2019 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RVL Pharmaceuticals plc quarterly/annual Return On Equity history and growth rate from 2019 to 2022.
  • RVL Pharmaceuticals plc Return On Equity for the quarter ending June 30, 2023 was -155 %, a 78.1% decline year-over-year.
  • RVL Pharmaceuticals plc annual Return On Equity for 2022 was -83.5 %, a 8.32% increase from 2021.
  • RVL Pharmaceuticals plc annual Return On Equity for 2021 was -91.1 %, a 48.5% decline from 2020.
  • RVL Pharmaceuticals plc annual Return On Equity for 2020 was -61.3 %, a 49.7% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -83.5 +7.58 +8.32% Jan 1, 2022 Dec 31, 2022
2021 -91.1 -29.8 -48.5% Jan 1, 2021 Dec 31, 2021
2020 -61.3 +60.5 +49.7% Jan 1, 2020 Dec 31, 2020
2019 -122 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.